Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-05 Sale |
2024-09-05 7:51 pm |
Athira Pharma Inc. | ATHA | Gengos Andrew CFO and Chief Business Officer |
1,272 | $0.566 | $720 | 97,532 (Direct) |
View |
| 2024-01-05 Sale(A) |
2024-02-16 4:34 pm |
Athira Pharma Inc. | ATHA | Gengos Andrew CFO AND CHIEF BUSINESS OFFICER |
1,208 | $2.91 | $3,515 | 83,804 (Direct) |
View |
| 2023-01-05 Sale |
2024-01-08 4:42 pm |
Athira Pharma Inc. | ATHA | Gengos Andrew See Below |
1,208 | $2.91 | $3,515 | 83,804 (Direct) |
View |
| 2023-06-07 Purchase |
2023-06-09 5:06 pm |
Athira Pharma Inc. | ATHA | Gengos Andrew See Below |
15,000 | $3.4297 | $51,445 | 80,012 (Direct) |
View |
| 2023-06-02 Purchase |
2023-06-06 7:36 pm |
Athira Pharma Inc. | ATHA | Gengos Andrew See Below |
65,012 | $2.9467 | $191,572 | 65,012 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-24 Option Award |
2025-02-25 6:12 pm |
N/A 2035-02-23 |
Terns Pharmaceuticals Inc. | TERN | Gengos Andrew Chief Financial Officer |
750,000 | $0 | 750,000 (Direct) |
View |
| 2024-09-03 Option Award |
2024-09-05 7:51 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Gengos Andrew CFO and Chief Business Officer |
5,000 | $0 | 97,532 (Direct) |
View |
| 2024-05-20 Option Award |
2024-09-05 7:51 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Gengos Andrew CFO and Chief Business Officer |
10,000 | $1.34 | 97,532 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:48 pm |
N/A 2034-02-13 |
Athira Pharma Inc. | ATHA | Gengos Andrew CFO AND CHIEF BUSINESS OFFICER |
280,000 | $0 | 280,000 (Direct) |
View |
| 2024-01-04 Option Award(A) |
2024-02-16 4:34 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Gengos Andrew CFO AND CHIEF BUSINESS OFFICER |
5,000 | $0 | 83,804 (Direct) |
View |
| 2023-01-04 Option Award |
2024-01-08 4:42 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Gengos Andrew See Below |
5,000 | $0 | 83,804 (Direct) |
View |
| 2023-05-18 Option Award |
2023-05-22 5:53 pm |
N/A 2033-05-17 |
Athira Pharma Inc. | ATHA | Gengos Andrew See Below |
400,000 | $0 | 400,000 (Direct) |
View |
Ownership |
2023-05-22 5:51 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Gengos Andrew See Below |
0 | $0 | 0 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 4:57 pm |
N/A 2032-02-22 |
Cyteir Therapeutics Inc. | CYT | Gengos Andrew Chief Business Officer |
35,000 | $0 | 35,000 (Direct) |
View |
Ownership |
2021-06-17 9:15 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Gengos Andrew Chief Business Officer |
0 | $0 | 378,682 (Direct) |
View |